T-047
(±)-Δ9-THC solution
100 μg/mL in heptane, ampule of 1 mL, Cerilliant®
조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
보기 변경
제품정보 (DICE 배송 시 비용 별도)
실험식(Hill 표기법):
C21H30O2
CAS 번호:
Molecular Weight:
314.46
UNSPSC Code:
41116107
EC Number:
205-563-8
NACRES:
NA.24
Quality Level
form
liquid
feature
Snap-N-Spike®/Snap-N-Shoot®
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
drug control
Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)
concentration
100 μg/mL in heptane
technique(s)
gas chromatography (GC): suitable, liquid chromatography (LC): suitable
application(s)
cannabis testing
format
single component solution
storage temp.
−20°C
SMILES string
O1C(C2C(c3c1cc(cc3O)CCCCC)C=C(CC2)C)(C)C
InChI
1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3
InChI key
CYQFCXCEBYINGO-UHFFFAOYSA-N
General description
(±)-Δ9-THC is the main active constituent and the primary psychoactive cannabinoid of cannabis. Besides persistent illicit use this drug is suitable as treatment for anorexia and nausea and is sold under the trade name Marinol®. This Certified Spiking Solution® is suitable as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications from forensic analysis and clinical toxicology to urine drug testing.
Other Notes
For Qualitative Use Only
Legal Information
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Marinol is a registered trademark of Unimed Pharmaceuticals, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
hcodes
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1 - Asp. Tox. 1 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Central nervous system
저장 등급
3 - Flammable liquids
wgk
WGK 2
flash_point_f
24.8 °F - closed cup
flash_point_c
-4 °C - closed cup
David R Maguire et al.
The Journal of pharmacology and experimental therapeutics, 345(3), 354-362 (2013-03-29)
Cannabinoid receptor agonists enhance the antinociceptive effects of μ-opioid receptor agonists, which suggests that combinations of these drugs might enhance therapeutic effectiveness (e.g., analgesia). However, it is not clear whether combinations of these drugs also enhance abuse or dependence liability.
Suspected dronabinol withdrawal in an elderly cannabis-naive medically ill patient.
Russ S Muramatsu et al.
The American journal of psychiatry, 170(7), 804-804 (2013-07-04)
M Waldman et al.
Biochemical pharmacology, 85(11), 1626-1633 (2013-03-30)
Tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is a cannabinoid agonist that exerts its effects by activating at least two specific receptors (CB1 and CB2) that belong to the seven transmembrane G-protein coupled receptor (GPCR) family. Both CB1 and
국제 무역 품목 번호
| SKU | GTIN |
|---|---|
| T-047-1ML | 04061837330094 |